Eftansomatropin alfa (GX-H9) comprises a recombinant human growth hormone fused to hyFc, a synthetic hybrid Fc fragment. It is under investigation for the treatment of growth hormone deficiency.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.